Creso Pharma Ltd News

Creso Pharma Ltd: LOI to Import MDMA & Psilocybin Treatments to Australia

Jun 9, 2023 07:42

Creso Pharma Ltd: Mernova Appoints CannDelta to Map EU GMP Export Process

Jun 5, 2023 06:53

Creso Pharma Ltd: Mernova Q2 Sales Update

May 22, 2023 08:26

Creso Pharma Ltd: Trading Halt

May 17, 2023 07:29

Creso Pharma Ltd: Response to Financial Condition Query

May 16, 2023 14:07

Creso Pharma Ltd: Creso Pharma Expands Asia Market Footprint

May 15, 2023 07:22

Creso Pharma Ltd: Response to ASX Price Query

May 10, 2023 08:01

Creso Pharma Ltd: Sierra Sage Herbs LLC Update

May 10, 2023 07:54

Creso Pharma Ltd: Halucenex Phase II Clinical Trial Update

May 5, 2023 07:45

Creso Pharma Ltd: Mernova - Eighth Province Entry & $553k in New POs

May 1, 2023 08:19

Creso Pharma Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 28, 2023 15:01

Creso Pharma Ltd: Mernova - Q1 Cashflow Positive With Record Revenues

Apr 19, 2023 07:54

Creso Pharma Ltd: ASX Listing Rule 3.13.1 Notice Regarding AGM

Apr 14, 2023 16:49

Creso Pharma Ltd: Appendix 4G and Corporate Governance Statement

Mar 31, 2023 13:49

Creso Pharma Ltd: Censure of Creso Pharma Limited

Mar 13, 2023 13:40

Creso Pharma Ltd: $2.5M Con Note Issue, Rollover & Extinguishment of Debt

Mar 6, 2023 06:49

Creso Pharma Ltd: Trading Halt

Feb 15, 2023 06:49

Creso Pharma Ltd: Restricted Securities to be Released from Escrow

Feb 14, 2023 15:48

Creso Pharma Ltd: Creso reports strong progress across business units

Feb 9, 2023 07:38

Creso Pharma Ltd: Halucenex to pursue AUS entry after landmark TGA decision

Feb 7, 2023 06:26